The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply. CBS News New York reporter Ali Bauman reports on whether the supply change could lead to consumers paying more.
QUINIX News: Pope Francis’ condition remains critical after respiratory crisis, says the Holy See
February 23, 2025
No Comments
